HR+ Metastatic Breast Cancer
2 clinical trials · Condition
◉ Watch HR+ Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases (NCT04923542) | H. Lee Moffitt Cancer Center and Research Institute | 2021-11-30 |
| A Study to Determine Safety and Tolerability of GMI-1359 in Subjects With HR+ Metastatic Breast Cancer (NCT04197999) | GlycoMimetics Incorporated | 2019-11-21 |
Track HR+ Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.